Wedgewood Partners’s Abiomed Inc ABMD Stock Holding History

Wedgewood Partners’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,000	Closed	-$260K	–	40
2019 Q2	$260K	Buy	+1,000	New	+$265K	0.02%	37

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Wedgewood Partners's ABMD Position: Q3 2019 in Review

Wedgewood Partners sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 1,000 shares — an estimated $260K sold.

Wedgewood Partners first reported a position in ABMD in Q2 2019 and held it in 1 quarter. The position peaked at $260K in Q2 2019. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

Wedgewood Partners reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
Wedgewood Partners sold 1,000 Abiomed Inc shares in Q3 2019, an estimated $260K.
Wedgewood Partners first reported a position in Abiomed Inc in Q2 2019 and held it in 1 quarter.
Wedgewood Partners's Abiomed Inc position peaked at $260K in Q2 2019.
443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Wedgewood Partners's 13F filing for Q3 2019, filed 14 Nov 2019.